QR kȏd

Real-world treatment patterns and sequencing in patients with advanced / metastatic HR+/HER2- breast cancer in Europe and the United States

Background: For patients with advanced breast cancer (ABC), standard-of-care (SOC) treatment in first line (1L) with CDK4/6 inhibitors (CDK4/6i) in combination with endocrine therapy (ET) is well established. However, data on treatment patterns in second line (2L), where the treatment landscape is e...

Cijeli opis

Spremljeno u:
Glavni autori: Reshma Mahtani, Beata Korytowsky, Chloe Grace Rose, Maria Jakobsson, Joseph Cappelleri, Katie Lewis, Annabel Lambert, Chloe Hammond, Carmen Criscitiello
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2026-04-01
Serija:Breast
Teme:
Breast cancer
Treatment patterns
Biomarker testing
Immunotherapy
CDK4/6i
Metastatic treatment
Online pristup:http://www.sciencedirect.com/science/article/pii/S0960977626000421
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti